Abstract:Objective: To explore the genetic basis of two fetuses with an osteogenesis imperfecta (OI) phenotype. Methods: Two fetuses diagnosed at the Affiliated Hospital of Weifang Medical College respectively on June 11, 2021 and October 16, 2021 were selected as the study subjects. Clinical data of the fetuses were collected. Amniotic fluid samples of the fetuses and peripheral blood samples of their pedigree members were collected for the extraction of genomic DNA. Whole exome sequencing (WES) and Sanger sequencing were carried out to identify the candidate variants. Minigene splicing reporter analysis was used to validate the variant which may affect the pre-mRNA splicing. Results: For fetus 1, ultrasonography at 17+6 weeks of gestation had revealed shortening of bilateral humerus and femurs by more than two weeks, in addition with multiple fractures and angular deformities of long bones. WES revealed that fetus 1 had harbored a heterozygous c.3949_3950insGGCATGT (p.N1317Rfs*114) variant in exon 49 of the COL1A1 gene (NM_000088.4). Based on the guidelines from the American College of Medical Genetics and Genomics (ACMG), it was classified as a pathogenic variant (PVS1+PS2+PM2_Supporting) for disrupting the downstream open reading frame resulting in premature translational termination, being de novo in origin, and lacking records in the population and disease databases.For fetus 2, ultrasonography at 23 weeks of gestation also revealed shortening of bilateral humerus and femurs by one and four weeks, respectively, in addition with bending of bilateral femurs, tibias and fibulas. Fetus 2 had harbored a heterozygous c.1557+3A>G variant in intron 26 of the COL1A2 gene (NM_000089.4). Minigene experiment showed that it has induced skipping of exon 26 from the COL1A2 mRNA transcript, resulting in an in-frame deletion (c.1504_1557del) of the COL1A2 mRNA transcript. The variant was inherited from its father and had been previously reported in a family with OI type 4. It was therefore classified as a pathogenic variant (PS3+PM1+PM2_Supporting+PP3+PP5). Conclusion: The c.3949_3950insGGCATGT (p.N1317Rfs*114) variant in the COL1A1 gene and c.1557+3A>G variant in the COL1A2 gene probably underlay the disease in the two fetuses. Above findings not only have enriched the mutational spectrum of OI, but also shed light on the correlation between its genotype and phenotype and provided a basis for genetic counseling and prenatal diagnosis for the affected pedigrees.

Dual Diagnosis of Osteogenesis Imperfecta (OI) and Short Stature and Advanced Bone Age with or Without Early-Onset Osteoarthritis And/or Osteochondritis Dissecans (SSOAOD) Reveals a Cumulative Effect on Stature Caused by Mutations in COL1A1 and ACAN Genes.

A novel mutation leading to elongation of the deduced α1(X) chain results in Metaphyseal Chondrodysplasia type Schmid.

Mutation Detection of COL1A1 Gene in a Pedigree with Osteogenesis Imperfecta

Genotype and Phenotype Analysis of Taiwanese Patients with Osteogenesis Imperfecta

A G560S Mutation in Alpha1 (I) Collagen Causes Familial Osteogenesis Imperfecta Type IV.

Application of Next-Generation Sequencing for Molecular Diagnosis in a Large Family with Osteogenesis Imperfecta Type I

Prenatal Cases Reflect the Complexity of the COL1A1/2 Associated Osteogenesis Imperfecta

A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family

Age At Onset-Dependent Presentations Of Premature Hip Osteoarthritis, Avascular Necrosis Of The Femoral Head, Or Legg-Calve-Perthes Disease In A Single Family, Consequent Upon A P.Gly1170ser Mutation Of Col2a1

The chemokine SDF-1alpha triggers a chemotactic response and induces cell polarization in human B lymphocytes.

High bone mass phenotype in a cohort of patients with Osteogenesis Imperfecta caused due to BMP1 and C-propeptide cleavage variants in COL1A1

Genetic Anomalies in Pediatric Orthopedics: A Case Study of a New Rare Sporadic Mutation of Osteogenesis Imperfecta

Genotypic and Phenotypic Analysis in Chinese Cohort With Autosomal Recessive Osteogenesis Imperfecta

[Analysis of COL1A1 and COL1A2 gene variants in two fetuses with osteogenesis imperfecta]

Altered Sox9 and FGF signaling gene expression in Aga2 OI mice negatively affects linear growth

Molecular Genetic Diagnosis with Targeted Next Generation Sequencing in a Cohort of Turkish Osteogenesis Imperfecta Patients and Their Genotype-phenotype Correlation

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Clinical severity prediction in children with osteogenesis imperfecta caused by COL1A1/2 defects

Mutations in COL1A1 of Type I Collagen Genes in Chinese Patients with Osteogenesis Imperfecta

Association between COL1A1 gene polymorphisms and bone size in Caucasians

Effectiveness of whole exome sequencing analyses in the molecular diagnosis of osteogenesis imperfecta